Efficacy and safety of glycopyrrolate/eFlow® CS (nebulized glycopyrrolate) in moderate-to-very-severe COPD: Results from the glycopyrrolate for obstructive lung disease via electronic nebulizer (GOLDEN) 3 and 4 randomized controlled trials

Autor: Kerwin, Edward, Donohue, James F., Goodin, Thomas, Tosiello, Robert, Wheeler, Alistair, Ferguson, Gary T.
Zdroj: In Respiratory Medicine November 2017 132:238-250
Databáze: ScienceDirect